NICE approves apixaban for treatment of DVT and pulmonary embolism

Patients can be given apixaban (Eliquis) on the NHS for the prevention and treatment of deep vein thrombosis and pulmonary embolism, NICE has ruled.

To treat deep vein thrombosis or pulmonary embolism, patients should be prescribed 10mg of apixaban twice daily for the first 7 days. | SCIENCE PHOTO LIBRARY
To treat deep vein thrombosis or pulmonary embolism, patients should be prescribed 10mg of apixaban twice daily for the first 7 days. | SCIENCE PHOTO LIBRARY

Apixaban directly inhibits factor Xa, suppressing thrombin formation and development of thrombi. Patients take an oral dose twice daily. 

Further information
NICE technology appraisal TA341

Apixaban is already recommended by NICE for prevention of stroke and systemic embolism in adults with nonvalvular atrial fibrillation and prevention of venous thromboembolism after total hip or knee replacement in adults.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more